Communiqués Repligen Corporation

Actions

RGEN

US7599161095

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 02/07/2026			Varia. 5j.	Varia. 1 janv.
142,40 ^USD	+2,45%		-3,14%	-13,10%

03/06	Transcript : Repligen Corporation Presents at 46th Annual William Blair Growth Stock Conference, Jun-03-2026 10:40 AM
15/05	Repligen devrait profiter de multiples leviers de croissance, selon RBC	MT

Communiqués

22/05	Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference	AQ
20/05	Repligen : 2025 Sustainability Report	PU
20/05	Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report	AQ
07/05	Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference	AQ
05/05	Repligen: Q1 Earnings Snapshot	AQ
05/05	Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance	AQ
22/04	Repligen to Report First Quarter 2026 Financial Results	AQ
17/04	Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network	AQ
05/03	Repligen Corporation to Present at Upcoming March Conferences	AQ
24/02	Repligen: Q4 Earnings Snapshot	AQ
24/02	Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance	AQ
10/02	Repligen to Report Fourth Quarter and Full Year 2025 Financial Results	AQ
14/01	Repligen : J.P. Morgan 2026 Healthcare Conference Repligen Presentation - J.P. Morgan 2026 Healthcare Conference	PU
06/01	Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair	AQ
18/12	Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference	AQ
16/12	Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows	AQ
26/11	Repligen Corporation to Present at Evercore Healthcare Conference	AQ
04/11	Repligen Corporation to Present at Upcoming November Conferences	AQ
28/10/25	Repligen: Q3 Earnings Snapshot	AQ
28/10/25	Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance	AQ
15/10/25	Repligen to Report Third Quarter 2025 Financial Results	AQ
25/09/25	Repligen : Bank of America Global Healthcare Conference Repligen Presentation	PU
25/08/25	Repligen Corporation to Present at Upcoming September Conferences	AQ
22/08/25	Repligen Corporation to Present at Upcoming September Conferences	AQ
31/07/25	Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization	AQ